Eucalyptus is an Australian digital health company that operates a portfolio of vertically integrated, demographic-focused telehealth brands. Its consumer brands include Juniper (women's weight management and menopause, including GLP-1 therapies), Pilot (men's health, hair loss, sexual wellness and weight loss), Software (prescription skincare and dermatology) and Kin (fertility and reproductive health). The company combines online consultations with licensed clinicians, prescription fulfillment and ongoing health coaching, operating in Australia, the United Kingdom, Germany, Japan and Canada, and has served more than 775,000 customers.
Eucalyptus has been acquired
This company is no longer available on our private secondary market.
Company data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Founded
2019
Employees
700–900
Total Funding
$227.7M
6 rounds
Latest Valuation
$0.89B
Nov 1, 2025
Completed acquisition by Hims & Hers, deal valued up to $1.15B, ~$240M cash at closing (June 2, 2026).
Change of control; Eucalyptus now a Hims & Hers subsidiary, no independent equity path remains.
Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Total raised $227.7M across 6 rounds
Last updated 08-11-2026
| Date | Round | Amount Raised | Valuation | Lead Investors |
|---|---|---|---|---|
| Nov 2025 | Series D | $124M | $0.89B | Not disclosed |
| Apr 2023 | Series C extension | $33M | $0.37B | BOND Capital |
| Jan 27, 2022 | Series C | $42M | — | BOND Capital |
Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Entry · Seed
$5M
Oct 2019
Eucalyptus today
$893M
Nov 2025 · latest mark
Eucalyptus multiple
168x
valuation uplift since first round
Y-axis is logarithmic. Hollow dots = estimated valuations. Does not represent realized investor returns.
Tim Doyle
Co-Founder & CEO
Charlie Gearside
Co-Founder
Benny Kleist
Co-Founder
Alexey Mitko
Co-Founder
Competitor list is illustrative and may be incomplete, stale, or erroneous.
Hims & Hers Health
NYSE-listed US direct-to-consumer telehealth platform offering men's and women's health, weight loss, dermatology and sexual wellness; pending acquirer of Eucalyptus.
Ro (Roman Health)
US direct-to-consumer telehealth company offering men's health, weight management (GLP-1) and skincare services.
Mosh
Australian direct-to-consumer telehealth provider focused on men's health including hair loss, skin and weight management.
InstantScripts
Australian online prescription and telehealth service; acquired by Wesfarmers in 2023.
Numan
UK-based men's health and weight management telehealth platform, competing with Eucalyptus's Pilot brand in the UK.
Noom
US-based digital weight management and behavior change platform with GLP-1 prescribing services, competing with Juniper.
Access live market data
Sign UpData collected with AI, which can make mistakes. Please double-check this information.